Business
AstraZeneca and Johnson and Johnson to continue COVID-19 immunization preliminaries as U.S. day by day cases top 71,000
On Friday, both AstraZeneca and Johnson and Johnson reported that their Covid immunization preliminaries are set to continue in the U.S. in the wake of hitting stop when volunteers got wiped out. The Food and Drug Administration gave the green light after examinations found no connection between those cases and Read more…